Fluoroquinolone-Clozapine Interaction — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Ciprofloxacin
Ciprofloxacin is the correct answer. It inhibits CYP1A2, an important pathway in clozapine metabolism, and can therefore increase clozapine exposure and precipitate concentration-related adverse effects such as sedation, confusion, tachycardia, myoclonus or seizures. The ciprofloxacin SmPC documents increases of approximately 29% in clozapine and 31% in N-desmethylclozapine concentrations after co-administration, although larger and clinically severe increases can occur in practice. Amoxicillin, cefalexin, nitrofurantoin and trimethoprim do not produce the same established CYP1A2-mediated interaction. Infection itself can also increase clozapine concentrations through inflammation-mediated suppression of metabolism, but the stem excludes systemic inflammation to isolate the pharmacokinetic interaction.
Reference: Electronic Medicines Compendium, Ciprofloxacin 250 mg film-coated tablets, SmPC sections 4.4 and 4.5, revised 2026: https://www.medicines.org.uk/emc/product/7256/smpc